Bioreactor Family Includes Single-Use Bags

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2017
Volume 41
Issue 7
Pages: 12

The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.

The BIOSTAT STR bioreactor family from Sartorius Stedim Biotech is a scalable, single-use bioreactor family based on a conventional stirred-tank design. The new bioreactor range includes upgraded hardware and software, as well as a fully integrated, new design of Flexsafe STR single-use bags. The bioreactor series, consisting of five systems in different sizes, offers working volumes from 12.5 L to 2000 L. Linear scale-up and process transfer from 250 mL to 2000 L can be achieved in weeks. The self-contained design of the new bioreactor with its single-use bag prevents product cross contamination, saving time in set-up, validation, clean-in-place procedures, and sterilize-in-place operations.

The system is designed for efficient oxygen transfer, mixing, and CO2 stripping. These combined features ensure cell culture performance with reproducible high-density growth of even sensitive cell lines. As a result, BIOSTAT STR bioreactors are suitable for achieving very high cell densities in continuous processes and for safe manufacture of vaccines and recombinant proteins in cGMP environments. Pictured is the BIOSTAT STR bioreactor in 500 L. 

Sartorius Stedim Biotech

 

 

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content